163 related articles for article (PubMed ID: 31902948)
1. High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma.
Qian T; Cui L; Liu Y; Cheng Z; Quan L; Zeng T; Huang W; Dai Y; Chen J; Liu L; Chen J; Pang Y; Wu G; Ye X; Shi J; Fu L; Si C
Pharmacogenomics J; 2020 Aug; 20(4):563-573. PubMed ID: 31902948
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
3. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
5. CCT3 as a Diagnostic and Prognostic Biomarker in Cervical Cancer.
Li M; Zeng J; Chang Y; Lv L; Ye G
Crit Rev Eukaryot Gene Expr; 2023; 33(6):17-28. PubMed ID: 37522542
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
7. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
Liu Y; Zhang X; Lin J; Chen Y; Qiao Y; Guo S; Yang Y; Zhu G; Pan Q; Wang J; Sun F
Cell Death Dis; 2019 Sep; 10(9):644. PubMed ID: 31501420
[TBL] [Abstract][Full Text] [Related]
8. CCT3 suppression prompts apoptotic machinery through oxidative stress and energy deprivation in breast and prostate cancers.
Temiz E; Koyuncu İ; Sahin E
Free Radic Biol Med; 2021 Mar; 165():88-99. PubMed ID: 33508424
[TBL] [Abstract][Full Text] [Related]
9. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
Shi H; Zhang Y; Wang Y; Fang P; Liu Y; Li W
Toxicol Appl Pharmacol; 2022 Mar; 439():115926. PubMed ID: 35182550
[TBL] [Abstract][Full Text] [Related]
10. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Zhang Y; Wang Y; Wei Y; Wu J; Zhang P; Shen S; Saiyin H; Wumaier R; Yang X; Wang C; Yu L
Cancer Lett; 2016 Mar; 372(1):101-9. PubMed ID: 26739059
[TBL] [Abstract][Full Text] [Related]
11. Miles to go (mtgo) encodes FNDC3 proteins that interact with the chaperonin subunit CCT3 and are required for NMJ branching and growth in Drosophila.
Syed A; Lukacsovich T; Pomeroy M; Bardwell AJ; Decker GT; Waymire KG; Purcell J; Huang W; Gui J; Padilla EM; Park C; Paul A; Pham TBT; Rodriguez Y; Wei S; Worthge S; Zebarjedi R; Zhang B; Bardwell L; Marsh JL; MacGregor GR
Dev Biol; 2019 Jan; 445(1):37-53. PubMed ID: 30539716
[TBL] [Abstract][Full Text] [Related]
12. Current understanding on the role of CCT3 in cancer research.
Liu W; Lu Y; Yan X; Lu Q; Sun Y; Wan X; Li Y; Zhao J; Li Y; Jiang G
Front Oncol; 2022; 12():961733. PubMed ID: 36185198
[TBL] [Abstract][Full Text] [Related]
13. Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression.
Liu W; Zhang X; Chen C; Li Y; Yang C; Han Z; Jiang G; Liu Y
J Cancer; 2022; 13(6):1958-1971. PubMed ID: 35399722
[TBL] [Abstract][Full Text] [Related]
14. Chaperonin containing TCP-1 subunit 3 is critical for gastric cancer growth.
Li LJ; Zhang LS; Han ZJ; He ZY; Chen H; Li YM
Oncotarget; 2017 Dec; 8(67):111470-111481. PubMed ID: 29340068
[TBL] [Abstract][Full Text] [Related]
15. Suppression of
Shi X; Cheng S; Wang W
Oncol Lett; 2018 Jun; 15(6):9202-9208. PubMed ID: 29805652
[TBL] [Abstract][Full Text] [Related]
16. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma.
Qian EN; Han SY; Ding SZ; Lv X
Cancer Cell Int; 2016; 16():55. PubMed ID: 27390551
[TBL] [Abstract][Full Text] [Related]
17. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
Zhan F; Barlogie B; Arzoumanian V; Huang Y; Williams DR; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Zangari M; Dhodapkar M; Shaughnessy JD
Blood; 2007 Feb; 109(4):1692-700. PubMed ID: 17023574
[TBL] [Abstract][Full Text] [Related]
18. Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.
Dong L; Chen CY; Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
Genet Mol Res; 2015 Aug; 14(3):9571-84. PubMed ID: 26345890
[TBL] [Abstract][Full Text] [Related]
19. Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis.
Showalter AE; Martini AC; Nierenberg D; Hosang K; Fahmi NA; Gopalan P; Khaled AS; Zhang W; Khaled AR
Sci Rep; 2020 Jan; 10(1):798. PubMed ID: 31964905
[TBL] [Abstract][Full Text] [Related]
20. Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.
Huang X; Wang X; Cheng C; Cai J; He S; Wang H; Liu F; Zhu C; Ding Z; Huang X; Zhang T; Zhang Y
APMIS; 2014 Nov; 122(11):1070-9. PubMed ID: 24862099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
